DD:
http://www.pharmaceutical-journal.com/news-an...49.article


http://endonovo.com/cytotronics-platform/ (ENDV has Multiple Platforms!)


http://endonovo.com/tvemf-vs-pemf/



http://nypost.com/2017/04/12/apple-has-a-secr...reatments/


https://www.google.com/amp/mobile.reuters.com...SKCN10C1K8

http://smallcapexclusive.com/duggan-robert-pi...se-shares/

https://www.forbes.com/profile/robert-duggan/



ENDV is the leader Bio electronics further along than Apple & Google/GSK Galvani Bio sciences subsidiary, and Pulse Biosciences PLSE ran from $4-$35 ENDV will see a a legendary run in the coming weeks and months. My target is $4:00-$5:00 than up List to Nasdaq next double digit dollars.


PLSE market cap 425 Million. Robert Duggan the founder of PCYC sold for 21 Billion just took a 19% stake in PLSE


Apple Bio electronics Biz is intrinsically worth a billion or more.


Galvani Bio Sciences is worth Billion or more with Google/GSK ponied up 750 Million for research and development.


The President of ENDV has spent half his salary over the last 12 months buying open market shares of ENDV every week. At an average cost of .26 He owns close to 21 Million shares. Total insiders hold over 41 million shares.



I think this has the makings of gapping up for the weeks and months ahead and running hard all day and the coming weeks and months Double Digit Dollar sustained run possibly triple digit dollars



Bring on the epic short squeeze. & the Milestone updates.



Anything under .25 is a gift